메뉴 건너뛰기




Volumn 15, Issue 7, 2012, Pages 429-432

Antifungal susceptibility of the Aspergillus species by etest and CLSI reference methods

Author keywords

Amphotericin B; Aspergillus; Etest; Itraconazole; Voriconazole

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; KETOCONAZOLE; VORICONAZOLE;

EID: 84865637567     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (34)

References (13)
  • 1
    • 0033827496 scopus 로고    scopus 로고
    • Invitro susceptibility testing of filamentous fungi: Comparison of Etest and reference microdilution methods for determining itraconazole MICs
    • Pfaller MA, Messer SA, Mills K, Bolmström A. Invitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICs. J ClinMicrobiol. 2000; 38: 3359-3361.
    • (2000) J ClinMicrobiol , vol.38 , pp. 3359-3361
    • Pfaller, M.A.1    Messer, S.A.2    Mills, K.3    Bolmström, A.4
  • 2
    • 0032944880 scopus 로고    scopus 로고
    • Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds
    • Szekely A, Johnson EM, Warnock DW. Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J ClinMicrobiol. 1996; 37: 1480-1483.
    • (1996) J ClinMicrobiol , vol.37 , pp. 1480-1483
    • Szekely, A.1    Johnson, E.M.2    Warnock, D.W.3
  • 3
    • 0003443233 scopus 로고    scopus 로고
    • National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi
    • Wayne PA. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard. 2002; 28: 14.
    • (2002) Approved standard. , vol.28 , pp. 14
    • Wayne, P.A.1
  • 4
    • 0035217138 scopus 로고    scopus 로고
    • Antifungal susceptibility testing. New technology and clinical applications
    • Pfaller MA, Yu WL. Antifungal susceptibility testing. New technology and clinical applications. Infect Dis Clin North Am. 2001; 15: 1227-1261.
    • (2001) Infect Dis Clin North Am. , vol.15 , pp. 1227-1261
    • Pfaller, M.A.1    Yu, W.L.2
  • 5
    • 0036205764 scopus 로고    scopus 로고
    • Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillusspp. and other filamentous fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000
    • Pfaller MA, Messer SA, Hollis RJ, Jones RN. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillusspp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother. 2002; 46: 1032-1037.
    • (2002) Antimicrob Agents Chemother. , vol.46 , pp. 1032-1037
    • Pfaller, M.A.1    Messer, S.A.2    Hollis, R.J.3    Jones, R.N.4
  • 6
    • 19944432456 scopus 로고    scopus 로고
    • Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: Surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003
    • Hsueh PR, Lau YJ, Chuang YC, Wan JH, Huang WK, Shyr JM, et al. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003. Antimicrob Agents Chemother. 2005; 49: 512-517.
    • (2005) Antimicrob Agents Chemother. , vol.49 , pp. 512-517
    • Hsueh, P.R.1    Lau, Y.J.2    Chuang, Y.C.3    Wan, J.H.4    Huang, W.K.5    Shyr, J.M.6
  • 7
    • 73649092418 scopus 로고    scopus 로고
    • Molecular Identification and In-Vitro Susceptibility of Candida albicans and C. dubliniensis Isolated from Immunocompromised Patients
    • Badiee P, Alborzi A, Shakiba E, Ziyaeyan M, Rasuli M. Molecular Identification and In-Vitro Susceptibility of Candida albicans and C. dubliniensis Isolated from Immunocompromised Patients. IRCMJ. 2009; 11: 391-397.
    • (2009) IRCMJ. , vol.11 , pp. 391-397
    • Badiee, P.1    Alborzi, A.2    Shakiba, E.3    Ziyaeyan, M.4    Rasuli M.x5
  • 8
    • 79958058392 scopus 로고    scopus 로고
    • Susceptibility of Candida species isolated from immunocompromised patients to antifungal agents
    • Badiee P, Alborzi A, ShakibaE, Farshad S, Japoni A. Susceptibility of Candida species isolated from immunocompromised patients to antifungal agents. EMHJ. 2011; 17: 425-430.
    • (2011) EMHJ. , vol.17 , pp. 425-430
    • Badiee, P.1    Alborzi, A.2    Shakiba, E.3    Farshad, S.4    Japoni, A.5
  • 9
    • 0035007179 scopus 로고    scopus 로고
    • Optimal susceptibility testing conditions for detection of azole resistance in Aspergillusspp; NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards
    • Espinel-Ingroff A, Bartlett M, Chaturvedi V, Ghannoum M, Hazen KC, Pfaller MA, et al. Optimal susceptibility testing conditions for detection of azole resistance in Aspergillusspp; NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards. Antimicrob Agents Chemother. 2001; 45: 1828-1835.
    • (2001) Antimicrob Agents Chemother. , vol.45 , pp. 1828-1835
    • Espinel-Ingroff, A.1    Bartlett, M.2    Chaturvedi, V.3    Ghannoum, M.4    Hazen, K.C.5    Pfaller, M.A.6
  • 10
    • 0033978008 scopus 로고    scopus 로고
    • Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection
    • Johnson EM, Oakley KL, Radford SA, Moore CB, Warn P, Warnock DW, et al. Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection. J Antimicrob Chemother. 2000; 45: 85-93.
    • (2000) J Antimicrob Chemother. , vol.45 , pp. 85-93
    • Johnson, E.M.1    Oakley, K.L.2    Radford, S.A.3    Moore, C.B.4    Warn, P.5    Warnock, D.W.6
  • 11
    • 0037335806 scopus 로고    scopus 로고
    • In vitro susceptibility testing of Aspergillus spp: Comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs
    • Pfaller JB, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. In vitro susceptibility testing of Aspergillus spp: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs. J Clin Microbiol. 2003; 41: 1126-1129.
    • (2003) J Clin Microbiol. , vol.41 , pp. 1126-1129
    • Pfaller, J.B.1    Messer, S.A.2    Hollis, R.J.3    Diekema, D.J.4    Pfaller, M.A.5
  • 12
    • 0036701634 scopus 로고    scopus 로고
    • Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species
    • Meletiadis J, Mouton JW, Meis JF, Bouman BA, Verweij PE. Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol. 2002; 40: 2876-2885.
    • (2002) J Clin Microbiol. , vol.40 , pp. 2876-2885
    • Meletiadis, J.1    Mouton, J.W.2    Meis, J.F.3    Bouman, B.A.4    Verweij, P.E.5
  • 13
    • 0036259959 scopus 로고    scopus 로고
    • E-test method for testing susceptibilities of Aspergillusspecies to the new triazoles voriconazole and posaconazole and to established antifungal agents: Comparison with NCCLS broth microdilution method
    • Espinel-Ingroff A, Rezusta A. E-test method for testing susceptibilities of Aspergillusspecies to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method. J Clin Microbiol. 2002; 40: 2101-2107.
    • (2002) J Clin Microbiol , vol.40 , pp. 2101-2107
    • Espinel-Ingroff, A.1    Rezusta, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.